1. Choosing cross-over designs when few subjects are available;Bate;Comput. Stat. Data Anal.,2008
2. Design and Analysis of Bioavailability and Bioequivalence Studies;Chow,2008
3. European Medicines Agency, 2010. Guideline on the investigation of bioequivalence. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/01/WC500070039.pdf.
4. A critique of recent research on the two-treatment crossover design;Fleiss;Controlled Clin. Trials,1989
5. Food and Drug Administration, 2001. Guideline for industry: statistical approaches to establishing bioequivalence. Available from: https://www.fda.gov/downloads/drugs/guidances/ucm070244.pdf.